| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |